Cancer attractors: A systems view of tumors from a gene network dynamics and developmental perspective

Seminars in Cell and Developmental Biology

Volumn 20, Issue 7, 2009, Pages 869-876

  Huang, Sui ^a   Ernberg, Ingemar ^b   Kauffman, Stuart ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer stem cell; Differentiation therapy; Dynamical system; Epigenetic landscape; Gene regulatory network

Indexed keywords

TRANSCRIPTOME;

CANCER CELL; CANCER STEM CELL; CARCINOGENESIS; CARCINOID; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL TYPE; EMBRYONIC STEM CELL; GENE MUTATION; GENE REGULATORY NETWORK; GENETIC DIFFERENCE; GENETIC EPIGENESIS; HUMAN; ONTOGENY; PHENOTYPE; PLURIPOTENT STEM CELL; REVIEW; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

EID: 70349330663     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2009.07.003     Document Type: Review

References (74)

1. Virchow R.L.K. Cellular pathology. 1859 special ed. (1978), John Churchill, London, UK p. 204-7
2. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40 (2008) 499-507
3. Naxerova K., Bult C.J., Peaston A., Fancher K., Knowles B.B., Kasif S., et al. Analysis of gene expression in a developmental context emphasizes distinct biological leitmotifs in human cancers. Genome Biol 9 (2008) R108
4. Borczuk A.C., Gorenstein L., Walter K.L., Assaad A.A., Wang L., and Powell C.A. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 163 (2003) 1949-1960
5. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
6. Vogelstein B., and Kinzler K.W. The multistep nature of cancer. Trends Genet 9 (1993) 138-141
7. Cairns J. Mutation selection and the natural history of cancer. Nature 255 (1975) 197-200
8. Curtis H.J. Formal discussion of: somatic mutations and carcinogenesis. Cancer Res 25 (1965) 1305-1308
9. Baum B., Settleman J., and Quinlan M.P. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19 (2008) 294-308
10. Polyak K., and Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9 (2009) 265-273
11. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66 (2006) 1883-1890 [discussion 95-6]
12. Dick J.E. Stem cell concepts renew cancer research. Blood 112 (2008) 4793-4807
13. Xie K., and Abbruzzese J.L. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell 4 (2003) 245-247
14. Rubin H. On the nature of enduring modifications induced in cells and organisms. Am J Physiol 258 (1990) L19-L24
15. Clark Jr. W.H. The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression. Acta Oncol 34 (1995) 3-21
16. Feinberg A.P., Ohlsson R., and Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 7 (2006) 21-33
17. Strausberg R.L., Buetow K.H., Greenhut S.F., Grouse L.H., and Schaefer C.F. The cancer genome anatomy project: online resources to reveal the molecular signatures of cancer. Cancer Invest 20 (2002) 1038-1050
18. Weinstein I.B., and Joe A.K. Mechanisms of disease: oncogene addiction-a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol 3 (2006) 448-457
19. Luo J., Solimini N.L., and Elledge S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136 (2009) 823-837
20. Kauffman S. Differentiation of malignant to benign cells. J Theor Biol 31 (1971) 429-451
21. Huang S, Kauffman S. Complex gene regulatory networks-from structure to biological observables: cell fate determination. In: Meyers RA, editor. Encyclopedia of complexity and systems science. Springer; 2009.
22. Huang S., and Ingber D.E. A non-genetic basis for cancer progression and metastasis: self-organizing attractors in cell regulatory networks. Breast Dis 26 (2006) 27-54
23. Liotta L.A., and Kohn E.C. The microenvironment of the tumour-host interface. Nature 411 (2001) 375-379
24. Tlsty T.D., and Coussens L.M. Tumor stroma and regulation of cancer development. Annu Rev Pathol 1 (2006) 119-150
25. Hu M., and Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 18 (2008) 27-34
26. Boland C.R., and Goel A. Somatic evolution of cancer cells. Semin Cancer Biol 15 (2005) 436-450
27. Ptashne M. On the use of the word 'epigenetic'. Curr Biol 17 (2007) R233-R236
28. Huang S. Reprogramming cell fates: reconciling rarity with robustness. Bioessays 31 (2009) 546-560
29. Bonifer C., Hoogenkamp M., Krysinska H., and Tagoh H. How transcription factors program chromatin-lessons from studies of the regulation of myeloid-specific genes. Semin Immunol 20 (2008) 257-263
30. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., et al. The consensus coding sequences of human breast and colorectal cancers. Science 314 (2006) 268-274
31. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., et al. Patterns of somatic mutation in human cancer genomes. Nature 446 (2007) 153-158
32. Ding L., Getz G., Wheeler D.A., Mardis E.R., McLellan M.D., Cibulskis K., et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455 (2008) 1069-1075
33. Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K., et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456 (2008) 66-72
34. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321 (2008) 1807-1812
35. Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321 (2008) 1801-1806
36. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., et al. The genomic landscapes of human breast and colorectal cancers. Science 318 (2007) 1108-1113
37. Rhee S.Y., Wood V., Dolinski K., and Draghici S. Use and misuse of the gene ontology annotations. Nat Rev Genet 9 (2008) 509-515
38. Elfilali A., Lair S., Verbeke C., La Rosa P., Radvanyi F., and Barillot E. ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis. Nucleic Acids Res 34 (2006) D613-D616
39. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6 (2004) 1-6
40. Dhanasekaran S.M., Barrette T.R., Ghosh D., Shah R., Varambally S., Kurachi K., et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412 (2001) 822-826
41. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
42. Meyerson M., Franklin W.A., and Kelley M.J. Molecular classification and molecular genetics of human lung cancers. Semin Oncol 31 (2004) 4-19
43. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
44. Guo Y., Eichler G.S., Feng Y., Ingber D.E., and Huang S. Towards a holistic, yet gene-centered analysis of gene expression profiles: a case study of human lung cancers. J Biomed Biotechnol 2006 (2006) 69141
45. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101 (2004) 6062-6067
46. Sandberg R., and Ernberg I. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci USA 102 (2005) 2052-2057
47. Goodwin B.C., and Webster G.C. Rethinking the origin of species by natural selection. Riv Biol 92 (1999) 464-467
48. Gould S.J., and Lewontin R.C. The spandrels of San Marco and the Panglossian paradigm: a critique of the adaptationist programme. Proc R Soc Lond B Biol Sci 205 (1979) 581-598
49. Bernards R., and Weinberg R.A. A progression puzzle. Nature 418 (2002) 823
50. Klein C.A. Parallel progression of primary tumours and metastases. Nat Rev Cancer 9 (2009) 302-312
51. Delbrück M. Discussion. Unités biologiques douées de continuité génétique (1949), Colloques Internationaux du Centre National de la Recherche Scientifique: CNRS, Paris
52. Monod J., and Jacob F. Teleonomic mechanisms in cellular metabolism, growth, and differentiation. Cold Spring Harb Symp Quant Biol 26 (1961) 389-401
53. Kauffman S.A. Metabolic stability and epigenesis in randomly constructed genetic nets. J Theor Biol 22 (1969) 437-467
54. Kauffman S. Homeostasis and differentiation in random genetic control networks. Nature 224 (1969) 177-178
55. Kauffman S.A. The origins of order (1993), Oxford Univ. Press, New York
56. Waddington C.H. The strategy of the genes (1957), Allen and Unwin, London
57. Raj A., and van Oudenaarden A. Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 135 (2008) 216-226
58. Huang S., Eichler G., Bar-Yam Y., and Ingber D.E. Cell fates as high-dimensional attractor states of a complex gene regulatory network. Phys Rev Lett 94 (2005) 128701
59. Chang H.H., Hemberg M., Barahona M., Ingber D.E., and Huang S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 453 (2008) 544-547
60. Brock A., Chang H., and Huang S. Non-genetic heterogeneity-a mutation-independent driving force for the somatic evolution of tumours. Nat Rev Genet 10 (2009) 336-342
61. Losick R., and Desplan C. Stochasticity and cell fate. Science 320 (2008) 65-68
62. Jones P.A., and Taylor S.M. Cellular differentiation, cytidine analogs and DNA methylation. Cell 20 (1980) 85-93
63. Huang S., Guo Y.P., May G., and Enver T. Bifurcation dynamics of cell fate decision in bipotent progenitor cells. Dev Biol 305 (2007) 695-713
64. Enver T., Pera M., Peterson C., and Andrews P.W. Stem cell states, fates, and the rules of attraction. Cell Stem Cell 4 (2009) 387-397
65. Aldana M., Balleza E., Kauffman S., and Resendiz O. Robustness and evolvability in genetic regulatory networks. J Theor Biol 245 (2007) 433-448
66. Albert R., Jeong H., and Barabasi A.L. Error and attack tolerance of complex networks. Nature 406 (2000) 378-382
67. Wang J, Xu L, Wang EK, Huang S. The "potential" landscape of genetic circuits imposes the arrow of time in stem cell differentiation in review, submitted for publication.
68. Waddington C.H. Canalization of development and the inheritance of acquired characters. Nature 150 (1942) 563-565
69. Lochter A., and Bissell M.J. An odyssey from breast to bone: multi-step control of mammary metastases and osteolysis by matrix metalloproteinases. Apmis 107 (1999) 128-136
70. Plattner R., Anderson M.J., Sato K.Y., Fasching C.L., Der C.J., and Stanbridge E.J. Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proc Natl Acad Sci USA 93 (1996) 6665-6670
71. Acevedo V.D., Gangula R.D., Freeman K.W., Li R., Zhang Y., Wang F., et al. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 12 (2007) 559-571
72. Zhang Z., Yuan X.M., Li L.H., and Xie F.P. Transdifferentiation in neoplastic development and its pathological implication. Histol Histopathol 16 (2001) 1249-1262
73. Rapp U.R., Ceteci F., and Schreck R. Oncogene-induced plasticity and cancer stem cells. Cell Cycle 7 (2008) 45-51
74. Nicolis G., and Prigogine I. Exploring complexity: an introduction (1989), W.H. Freeman & Company